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In Xenopus, the activation of the myogenic determination factors MyoD and Myf-5 in the muscle-forming region of the
embryo occurs in response to mesoderm-inducing factors (MIFs). Different members of the FGF, TGF-b, and Wnt protein
families have been implicated in this process, but how MIFs induce the myogenic regulators is not known. For MyoD, the
induction process may serve to locally stabilize a transient burst of ubiquitous transcription at the midblastula transition,
possibly by triggering MyoD’s autocatalytic loop. Here we have sought to distinguish separate activating functions during
MyoD induction by analyzing when MyoD responds to different MIF signaling or to MyoD autoactivation. We show that
MyoD induction depends on the developmental age of the induced cells, rather than on the type or time point of inducer
application. At the permissive time, de novo MyoD induction by Activin requires less than 90 min, arguing for an
immediate response, rather than a series of inductive events. MyoD autoactivation is direct, but subject to the same
temporal restriction as MyoD induction by MIF signaling. Further evidence implicating MyoD autocatalysis as an essential
component of the induction process comes from the observation that both autocatalysis and induction of MyoD are
selectively repressed by a dominant-negative MyoD mutant. In summary, our observations let us conclude that MyoD’s
expression domain in the embryo results from an interplay of timed changes in cellular competence, pleiotropic signaling
pathways, and autocatalysis. © 1998 Academic Press
INTRODUCTION
MyoD, Myf-5, Myogenin, and MRF4 comprise a small
family of myogenic transcriptional regulators in verte-
brates. In vitro, each of these four bHLH transcription
factors is capable of converting a large number of different
cell types into striated muscle. This remarkable feature is
in part explained by the fact that the myogenic proteins
bind to specific DNA consensus sites called E-boxes, which
are functionally important motifs of many muscle-specific
promoters and enhancer elements. In addition, they owe
much of their potency to auto- and crossregulatory interac-
tions among themselves and with members of the MEF-2
protein family (see Buckingham, 1994; Molkentin and Ol-
son, 1996; Weintraub et al., 1991a). In vivo, this self-
propagating genetic network is held in check by multiple
control mechanisms, which regulate both expression and
activity of the myogenic regulators (reviewed in Cossu et
al., 1996; Yun and Wold, 1996). Clearly, some of these
mechanisms are dominant over the myogenic differentia-
tion program, since widespread overexpression of MyoD or
Myf-5 in embryos causes some ectopic muscle formation,
but not a general transformation of embryonic cell lineages
into muscle (Hopwood et al., 1991; Ludolph et al., 1994;
Miner et al., 1992; Rupp et al., 1994; Santerre et al., 1993).
Targeted mutations in the mouse have revealed both
redundant and specific functions for the myogenic proteins
(reviewed in Olson et al., 1996; Olson and Klein, 1994;
Rudnicki and Jaenisch, 1995). The emerging consensus is
that MyoD and Myf-5 are involved in the formation or
survival of two myoblast lineages and that Myogenin is
required for efficient terminal myoblast differentiation,
while MRF4 is likely to have postembryonic functions. The
evidence for nonredundant functions, however, should be
taken with caution, since myogenin, when knocked in into
the myf-5 locus, can rescue the Myf-5 loss-of-function
phenotype (Wang et al., 1996). Functional diversity of
myogenic proteins may therefore be encoded—at least in
part—by different enhancer sequences, which control the
spatiotemporal expression of individual members of this
gene family (see Weintraub, 1993).
Skeletal muscle cells in vertebrates originate from the
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myotomal compartment of the somites. In amniota, spatial
and temporal specific expression patterns of the myogenic
genes are correlated with the formation of the myotome
(Buckingham, 1992; Pownall and Emerson, 1992; Smith et
al., 1993). Experiments in the chick suggest a complex
interplay of both stimulatory and inhibitory signals from
axial structures and dorsal ectoderm to be involved in
somite patterning and expression of the myogenic genes
(reviewed by Lassar and Mu¨nsterberg, 1996). Sonic hedge-
hog, Noggin, Wnt, and BMP-4 proteins are likely candidates
for some of these signals (see Pourquie´ et al., 1996; Reshef
et al., 1998). Interestingly, the sequence of MyoD and Myf-5
activation is reversed between avians and rodents (Pownall
and Emerson, 1992), and induction of MyoD and Myf-5 is
uncoupled from somitogenesis in zebrafish (Weinberg et al.,
1996) and Xenopus (Hopwood et al., 1989, 1991; Rupp and
Weintraub, 1991). Whether these differences are due to
different input signals, or whether the same signals become
engaged in muscle induction at different times and location
in different species, is currently not known.
A more profound, and still open, question is whether
these signaling pathways induce myogenic gene expression
or whether they are required to maintain or expand a
population of already specified cells. Clearly, mouse and
chick embryos contain low levels of MyoD and Myf-5
mRNAs at presomite stages (see Cossu et al., 1996; Kopan
et al., 1994), and myoD and myogenin genes are transiently
activated in chick somites, even in the absence of the
neural tube (Bober et al., 1994). Most strikingly, isolated
chick epiblast cells express MyoD and differentiate autono-
mously into muscle at very high frequency in vitro (George-
Weinstein et al., 1996). This suggests that MyoD-driven
muscle differentiation may be a kind of “default state” and
that signaling of the embryonic environment controls this
default state by general repression and local induction/
relieve from repression.
We had proposed a similar model of permissive Xenopus
MyoD induction (Rupp and Weintraub, 1991), based on the
observation that in the frog, MyoD is ubiquitously ex-
pressed at low levels for a short period of time following the
midblastula transition (MBT; Newport and Kirschner,
1982). This period precedes and overlaps with the
induction-dependent high-level MyoD expression in the
presumptive mesoderm, where MyoD mRNA (Frank and
Harland, 1991; Hopwood et al., 1989) and protein (Hopwood
et al., 1992) are detectable in situ from the midgastrula
stage onward. At this time MyoD is expressed in a
horseshoe-like pattern around the blastoporus in the prein-
voluted mesoderm, whose dorsal gap corresponds to the
Spemann organizer. This expression domain fits well to the
muscle fate map, which predicts both lateral and ventral
mesodermal cells to contribute to the trunk musculature
(Dale and Slack, 1987). In contrast, Myf-5 expression is
induced in two symmetric domains flanking the organizer,
but not in ventral mesoderm (Dosch et al., 1997). The early
activation of MyoD and Myf-5 probably has a determinative
function, because muscle-forming competence is lost in the
embryo (Grainger and Gurdon, 1989; Steinbach et al., 1997)
before myogenic precursors are comitted (Kato and Gurdon,
1993). Interestingly, MyoD is also strongly expressed, al-
though only transiently, in embryos, which have been
ventralized by UV irradiation (Frank and Harland, 1991).
Since such embryos develop no notochord, neural tissue, or
muscle, axial structures are required for the maintenance,
but not for the induction of MyoD expression in the frog.
The frog Xenopus laevis provides a particularly attractive
system for studying inductive cell–cell interactions, due to
the presence of pluripotential cells in the animal hemi-
sphere of the blastula. As tissue explants (“animal caps”),
these cells can be triggered to embark on multiple differen-
tiation programs in a way, which closely resembles the
normal induction and patterning of mesodermal and neu-
roectodermal tissues. Interestingly, these cells undergo
with increasing developmental age a series of cell-
autonomously programmed changes in competence (Servet-
nick and Grainger, 1991), which influence the tissue types
formed by inductive stimuli. Mesodermal competence lasts
from early cleavage to gastrula stages (Grainger and Gur-
don, 1989; Jones and Woodland, 1987), when it is lost as a
consequence of gene-selective transcriptional silencing by
somatic H1 linker histones (Steinbach et al., 1997). A large
number of secreted proteins have been implicated as induc-
ers in mesoderm induction (for reviews see Heasman, 1997;
Smith, 1995), and some of these factors have been reported
to promote myogenic gene expression and muscle differen-
tiation. The latter include members of the FGF and TGF-b
families of peptide growth factors (such as basic FGF,
Activin, or Vg-1), Wnt family members (in particular XWnt-
8), and bone morphogenetic proteins and their inhibitors
(e.g., BMP-4 and Noggin) (see Dosch et al., 1997; Hoppler et
al., 1996; Re’em-Kalma et al., 1995; Smith, 1995).
It is not known how these signaling factors activate
Xenopus MyoD. Because both MyoD mRNA and pre-
mRNA levels rise during this process (Harvey, 1990), MyoD
induction must be controlled—at least in part—on the
transcriptional level. According to our model, induction
may locally upregulate and stabilize basal MyoD transcrip-
tion by establishing a positive autoregulatory loop (Rupp
and Weintraub, 1991). In contrast, several other observa-
tions suggested that MyoD expression in the mesoderm
may result from a cascade of inductive events. First, MyoD
induction has been characterized as a delayed, cyclo-
heximide-sensitive response to Activin (Harvey, 1991). Sec-
ond, MyoD induction by Activin may be mediated by
XWnt-8, because zygotic XWnt-8 signaling is required for
MyoD expression in the ventrolateral mesoderm (Hoppler
et al., 1996) and because Activin is known to induce
XWnt-8 transcription in animal caps (Christian et al., 1992).
Third, MyoD’s autoactivation loop does not function at the
MBT, although injected MyoD protein is transcriptionally
active at this time (see Rupp et al., 1994). This indicates
that MyoD autocatalysis is developmentally regulated. In
the present study, we have sought to investigate the epi-
static relationships of mesoderm-inducing factors and
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MyoD autocatalysis by time course analysis of MyoD
induction in animal caps.
MATERIAL AND METHODS
Embryo Manipulations
The in vitro fertilization of eggs, culture of embryos, and
dissections of animal cap explants has been carried out as described
(see Rupp et al., 1994; Rupp and Weintraub, 1991). At 23°C
constant temperature in 0.13 modified Barth’s Saline (MBS), we
found embryos to develop slightly faster than described by Nieuw-
koop and Faber (1967). Embryos were microinjected with capped
synthetic transcripts, either into the animal pole at the two-cell
stage (10 nl/embryo) for preloading of animal cap tissue or equato-
rially into one cell (5 nl) at the two-cell stage for targeting the
transcripts to the somitogenic mesoderm. Animal cap explants
were cut at late blastula (6.75–7.5 hours postfertilization (hpf)) and
cultured singly in 0.53 MBS/2% BSA in 1% agarose/0.53 MBS-
coated plastic dishes. Activin A was applied as conditioned me-
dium of P388D1 cells (Sokol et al., 1990) diluted in 0.53 MBS/2%
BSA. Since animal caps round up rapidly after explantation, they
were either transferred immediately to Activin A-containing me-
dium or reopened mechanically with eyebrow knives to allow
growth factor access at the desired time points. To block protein
synthesis, animal caps were incubated with 10 mg/ml cycloheximid
(CHX; Sigma) in 0.53 MBS/2% BSA for 30 min and then rinsed
twice in 0.53 MBS/2% BSA. Under these conditions CHX inhibits
$90% of protein synthesis for several hours (Cascio and Gurdon,
1987). For hormone induction of the MyoD-GR variant, animal
caps were treated with 10 mM dexamethasone (DEX; Sigma) in 0.53
MBS/2% BSA (Kolm and Sive, 1995).
Plasmids and in Vitro RNA Synthesis
The pBSKS1-XMyoDb (Xenopus MyoDb; Rupp and Weintraub,
1991), pCS21-mMyoD (mouse MyoD; Rupp et al., 1994), p64T-
MD-GR (mouse MyoD–glucocorticoid receptor fusion gene; Kolm
and Sive, 1995), pSP64T-mbA (mouse Activin bA; Albano et al.,
1993), pCS21NLS-bgal (nuclear variant of Escherichia coli lacZ;
Steinbach et al., 1997), and pGEM5Zf (2)/RI-XWnt8 (Xenopus
Wnt-8; Smith and Harland, 1991) plasmids have been described
previously. pSP64T-HF37/bFGF encodes a bovine basic FGF vari-
ant, which by a single amino acid exchange has been converted into
human bFGF; it also includes a signal peptide for efficient secre-
tion. This variant is more active than wild-type Xenopus bFGF in
mesoderm induction assays (D. Kimelman, personal communica-
tion).
The repressor domain of the Drosophila-engrailed protein (enR;
amino acids 1–298; GenBank Accession No. M10017) was subcloned
in frame into the pCS21MT6 and pCS21NLSMT6 (Rupp et al., 1994)
by PCR from a Drosophila-engrailed cDNA, using the forward primer
59-GAAGGCCTACTAGTACAATGGCCCTGGAGGAT-39 and re-
verse primer 59-CCGCTCGAGAGGATCCCAGAGCAGATT-39
(primer-based StuI and XhoI restriction sites, which have been used
for subcloning, are underlined). The mouse MyoD (bHLH) domain
(amino acids 102–162) was amplified by PCR from the plasmid pVZ-
11s (Davis et al., 1987) using the forward primer 59-
CGGAATTCGGATATGGAGCTCAAGCGCAAGACCAC-39 and
the reverse pr imer 5 9 -GGACTAGTGTCGCGCAG-
CAGAGCCTGCA-39 and subcloned via the underlined EcoRI and
SpeI restriction sites into pCS21MT6-enR between the myc-epitope
tag and the enR domain to yield pCS21MT6-MyoD(bHLH)-enR.
pCS21MT6-E12basic(bHLH)-enR was generated by a similar strat-
egy, starting however with the plasmid pEMSV-MyoDE12basic
as PCR template and using a different forward primer, 59-
CGGAATTCGGATATGGAGCTTCAGAA GGCCGAGCGGGAG-
39, which matches to amino acid residues 552–557 of the human E12
protein (see Davis et al., 1990).
For in vitro transcription, plasmids were linearized with Asp718
(pCS21mMyoD, pCS21XMyoDb, pCS21NLSMT6-enR,
pCS21MT6-mMyoD(bHLH)-enR and pCS21MT6-E12basic(bHLH)-
enR), HindIII (pBSKS1XmyoDb), EcoRI (pSP64T-HF37/bFGF),
BamHI (p64T-MD-GR), Sma I (pSP64T-mbA), or Not I
(pGEM5Zf(2)/RI-XWnt8, pCS21NLS-bgal). The synthesis of
capped SP6 transcripts and of the digoxygenin-labeled XmyoDb
antisense probe for in situ hybridization was carried out as de-
scribed (see Steinbach et al., 1997).
RNA Analysis by Quantitative RT/PCR
Total cellular RNA from embryos and explants was prepared
with the Tristar protocol (AGS, Heidelberg, Germany). Random-
primed reverse transcription and PCR amplification of gene-
specific fragments were performed under conditions that ensure a
direct correlation between RNA template abundance and PCR
product amounts and strict dependence of PCR products on cDNA
synthesis (see Rupp and Weintraub, 1991; a detailed description is
available upon request). After gel electrophoresis, the relative PCR
product amounts were determined by quantitating incorporated
[a-32P]dCTP trace label with phosphor storage technology (Molecu-
lar Dynamics). Primer pairs for genes of interest were always used
in multiplex PCR with H4 primers as internal standards. Due to
the relative high abundance of H4 mRNA compared to other
transcripts, 9 cycles of preamplification were performed with
gene-specific primers, before the H4 primers were added, and
amplification continued for 19 additional cycles. The standard
temperature profile was denaturation (94°C for 30 s), primer
annealing (58°C for 30 s), and extension (72°C for 1 min). Data
points of independent experiments were calculated as arith-
metic means of duplicate RNA samples, each consisting of
three animal caps. They represent average increases in steady-
state mRNA levels of induced over uninduced explants after
normalization to histone H4 mRNA levels. Both XMyoDa and
XmyoDb genes responded similarly to the various experimen-
tal conditions, although relative mRNA levels of XMyoDa were
at least 10-fold lower than those of XMyoDb (not shown). For
the sake of simplicity we only present data for XMyoDb. The
following PCR primers have been used (F, forward; R, reverse):
XMyoDb, histone H4 (see Rupp and Weintraub, 1991; Steinbach et
al., 1997); Xmyf-5, 59-TCTAGCTGTTCAGATGGCA-39 (F), 59-
TTAAGAGAGGCTTATAACAC-39 (R) (positions 575–873; Gen-
Bank Accession No. X56738).
Whole Mount in Situ Hybridization
Whole mount in situ hybridization was performed as described
(Steinbach et al., 1997). XMyoDb sense RNA probes gave no
hybridization signals (data not shown). For lineage-tracing analysis,
embryos were fixed for 1 h, followed by b-galactosidase staining
(color development ,1 h).
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RESULTS
MyoD Induction Is Temporally Restricted
Mesoderm induction is thought to occur from the 64-cell
stage on to early gastrula (Jones and Woodland, 1987). Since
zygotic transcription starts at the midblastula transition
(Newport and Kirschner, 1982), there is 6 h time for the
transcriptional activation of mesodermal genes before me-
sodermal competence disappears (Grainger and Gurdon,
1989; Steinbach et al., 1997). In order to discriminate
between the relative contributions of growth factors and
MyoD autoactivation for MyoD expression we investigated
in developmental time course experiments when different
stimuli activate MyoD in animal caps (see Fig. 1). In
preparatory experiments we had found that bFGF alone
(#50 pg RNA/embryo of HF37; see Materials and Methods)
did not induce MyoD mRNA significantly (data not shown).
As expected, however, it strongly synergized with Xwnt-8,
which is not a mesoderm-inducing factor (Christian et al.,
1992), but is required for MyoD expression in the mesoderm
(Hoppler et al., 1996). To trigger mesoderm induction in
animal caps, we therefore coinjected synthetic transcripts
for bFGF and Xwnt-8 at the two cell stage or added Activin
protein (Sokol et al., 1990) to the explants immediately
after dissection. To promote MyoD autoactivation we in-
jected either mouse or high amounts of Xenopus MyoD
transcripts (see Rupp et al., 1994).
Unexpectedly, the kinetics of MyoD induction in animal
caps as estimated by quantitative RT/PCR were initially
indistinguishable between the various conditions (Fig. 2). In
each case, a significant and quantitatively comparable in-
crease in MyoD mRNA levels occurred between 9.75 and
10.5 hpf, i.e., around NF stage 10.25 (Nieuwkoop and Faber,
1967). The same result was found with animal caps, in
which Activin had been provided early by RNA microinjec-
tion at the two-cell stage (data not shown). Subsequently,
MyoD mRNA levels in general continued to accumulate
over time (Fig. 2, 24 hpf), correlated with muscle differen-
tiation (data not shown). An exception was XMyoD-
injected animal caps, which showed only a marginal in-
crease in endogenous XMyoD mRNA from 12 to 24 hpf and
which was the only activator tested, which did not cause
muscle differentiation in the explants (Hopwood and Gur-
don, 1990; O. C. Steinbach and R. A. W. Rupp, unpublished
results). The basis for the different activities of mouse and
Xenopus MyoD proteins in this assay is unknown. Impor-
tantly, the timing of MyoD induction in animal caps was
precisely correlated with the temporal upregulation of
MyoD mRNA in the mesoderm of unmanipulated sibling
embryos (Fig. 2, black bars), and therefore these results are
relevant for normal development.
The 4-h time gap between the start of zygotic transcrip-
tion at the MBT and MyoD induction seems to suggest that
MyoD mRNA accumulation is a secondary consequence of
mesoderm induction, which requires other immediate-
early response genes. Consistent with this assumption,
MyoD induction has been characterized as a delayed,
cycloheximide-sensitive response to Activin requiring be-
FIG. 2. The onset of MyoD induction. Columns show the average
increase of XMyoD steady-state mRNA levels as a function of time.
RNA samples were from control embryos or from animal cap
explants injected either with synthetic transcripts encoding
XmyoD (400 pg) or mouse MyoD (200 pg) or with a combination of
bFGF (50 pg) and XWnt-8 (10 pg) transcripts. In this series of
experiments, Activin induction was triggered by application of a
1:4 dilution of Activin-containing tissue culture supernatant at 7
hpf. For all five conditions tested, myoD induction occurs between
9.75 and 10.5 hpf. The relative XMyoD induction is calculated as
mRNA increase of induced over control explants of the same
developmental age, after normalization to H4 mRNA as internal
standard (see Materials and Methods for details). (n 5 3–5 indepen-
dent experiments; error bars, SD). Note the broken x-axis and the
different y-axis scale for the 24 hpf time point.
FIG. 1. Developmental time scale and flow diagram of experimen-
tal manipulations. Developmental time is given as hours post
fertilization (hpf). NF, Nieuwkoop and Faber stages. The mesoder-
mal competence period, represented by the black bar, lasts from
about 3.5 to 11.25 hpf. Where applicable, embryos were injected
into the animal hemisphere at the two-cell stage with capped,
synthetic transcripts. The application regimens for soluble reagents
are described in the respective figure legends. Animal caps were
routinely cut shortly after the midblastula transition (MBT), i.e.,
between 6.75 and 7.5 hpf and cultured until successively later time
points (F), at which time they were lysed and subjected to quanti-
tative RT/PCR analysis.
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tween 6 and 10 h (Harvey, 1991). Puzzled by the synchro-
nous activation of MyoD through several mechanistically
unrelated stimuli, we decided to determine the minimal
delay between Activin application and MyoD mRNA in-
crease. To do this, we applied Activin at 9.75 hpf to animal
cap explants, i.e., 45 min before MyoD activation occurs
(Fig. 3a). Under these conditions, MyoD mRNA levels
increased about 10-fold within 90 min, i.e., with a similar
slope as in our previous experiments (Fig. 2) and comparable
to induction kinetics of immediate-early response genes
such as Xbra (Smith et al., 1991) or Mix.1 (Rosa, 1989).
This rapid increase in MyoD mRNA in response to
Activin induction seems incompatible with a hierarchic
event, in which Activin triggers first transcription, transla-
tion, and secretion of Xwnt-8, which then induces MyoD.
To test this argument, we coexpressed a dominant-negative
XWnt-8 variant (dnXWnt-8; Hoppler et al., 1996) with the
various inducers in the animal cap. While we found that it
had no effect on MyoD expression driven by activin or
autocatalysis, dnXWnt-8 interfered—as expected—with
MyoD induction by bFGF/XWnt-8 (Fig. 4). Interestingly,
complete inhibition of MyoD activation by bFGF/XWnt-8
at 12 hpf required a time advance in the expression of the
dnXWnt-8 variant over the wild-type protein (compare
the second and third columns in Fig. 4a; see figure legend
for details), probably reflecting a requirement for high
protein levels of the interference mutant for efficient
competition with the wild-type XWnt-8 protein. At 24
hpf (Fig. 4b), however, MyoD was silenced even when
dnXWnt-8 was expressed simultaneously with bFGF/
XWnt-8 (see second columns in Figs. 4a and 4b). Similar
results were obtained in experiments, in which wild-type
XWnt-8 function was supplied by plasmid-borne tran-
scription (data not shown). Together, these experiments
may indicate a dual function for post-MBT XWnt-8
signaling in both activation and maintenance of MyoD
expression during (bFGF/XWnt-8)-mediated MyoD in-
duction.
In summary, we conclude that MyoD activation de-
pends primarily on the developmental age of the induced
cells, rather than on the type or time point of inducer
application. The same conclusion has been reported for
the timing of muscle actin expression (Gurdon et al.,
1985). Indeed, the latter may be explained explained by
the former, because exogenous MyoD protein is suffi-
cient to trigger precocious muscle actin expression at the
MBT (Rupp et al., 1994).
MyoD Autoactivation Is Direct
Despite its fast response, MyoD induction by Activin is
nevertheless completely inhibited by cycloheximide (Fig.
3a; see also Harvey, 1991), indicating the involvement of
some unstable protein(s) in this process. Theoretically,
this protein could be MyoD itself, since the gene is
transcribed ubiquitously at low levels from MBT through
gastrula stages (Rupp and Weintraub, 1991). Consistent
with this idea, we show in Fig. 3b that cycloheximide did
not interfere with myoD autoactivation, when either
mouse MyoD protein or high levels of XMyoD protein
(data not shown) were provided early through mRNA
injection.
We also tested MD-GR, a hormone-inducible variant of
FIG. 3. MyoD activation is a fast response to Activin, but requires
protein synthesis. (a) Addition of soluble Activin to animal caps at
9.75 hpf leads to an increase in XMyoD mRNA levels within 45 to
90 min. Explants, which were previously incubated with cyclohex-
imide (CHX) from 9.25 to 9.75 hpf, show no increase in XMyoD
mRNA. (b) mMyoD protein, translated from microinjected RNA,
promotes autoactivation in the absence of protein synthesis (CHX
treatment from 9.25 to 9.75 hpf). (c) MyoD autoactivation is direct.
In this experiment, autocatalysis is triggered by the dexameth-
asone-inducible MD-GR protein, which has been preexpressed by
mRNA injection at the two-cell stage (100 pg/embryo). After
protein synthesis has been blocked by CHX treatment as in a,
MD-GR is activated through dexamethasone application at 9.75
hpf. Note that MD-GR is completely inactive without dexameth-
asone (n 5 4 for each panel).
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mouse MyoD (Hollenberg et al., 1993). This fusion pro-
tein contains the ligand-binding domain of the human
glucocorticoid receptor inserted in frame into the MyoD-
coding region, and its activity depends strictly on glu-
cocorticoids (Hollenberg et al., 1993; Kolm and Sive,
1995). In the presence of dexamethasone, MD-GR pro-
moted MyoD transcription with the same efficiency as
Activin or wild-type MyoD protein (compare Figs. 3a and
3b), even when it was activated after protein synthesis
had been blocked by cycloheximide (Fig. 3c). Similar to
wild-type MyoD proteins (see Fig. 2), early activation of
MyoD-GR by dexamethasone at 7 hpf did not cause
precocious MyoD activation (Fig. 3c). We conclude that
the MyoD autoactivation loop is direct, but subject to the
same temporal restriction as the signal input of meso-
derm inducing factors in MyoD activation.
A Dominant-Negative MyoD Mutant Blocks MyoD
Activation
While we have demonstrated that MyoD autoactivation
can be triggered in animal caps by exogenous MyoD pro-
tein, we do not know whether it actually occurs in vivo. To
address this issue, we fused the transcriptional repressor
domain of the Drosophila-engrailed protein to MyoD’s
bHLH domain (together with a myc-epitope tag; see Mate-
rials and Methods). This follows an idea that has been first
applied for the c-myb protein (Badiani et al., 1994), as well
as for the analysis of Xbra functions in Xenopus (Conlon et
al., 1996). This MT6-MyoD(bHLH)-enR variant is expected
to compete with endogenous MyoD protein for cognate
DNA-binding sites and to repress transcription of MyoD
target genes.
Two control constructs were used to assess the specific-
ity of the MT6-MyoD(bHLH)-enR variant. The first, called
NLSMT6-enR, encodes a nuclear localized, myc-tagged
version of the enR domain; in the absence of a DNA-
binding domain, this variant should control for potential
squelching effects of the engrailed repressor domain. The
second construct, called MT6-E12basic(bHLH)-enR, is iden-
tical to MT6-MyoD(bHLH)-enR, except that MyoD’s basic
region has been replaced with the corresponding region
from MyoD’s nonmyogenic dimerization partner E12 (see
Davis et al., 1990). The basic region comprises the DNA-
binding domain of HLH transcription factors, and it has
been shown previously that a small number of specific
residues within this region, which are not found at the
corresponding positions in E12, encode the myogenic speci-
ficity of MyoD (discussed by Yun and Wold, 1996). In
analogy to the related parental MyoD-E12basic protein
(Davis et al., 1990), MT6-E12basic(bHLH)-enR is expected
to heterodimerize with E proteins and to bind to DNA, but
to lack myogenic specificity. Since a myogenic basic region
is required for MyoD autoactivation both in vitro (Wein-
traub et al., 1991b) and in vivo (Rupp et al., 1994), this
variant might be predicted not to interfere with MyoD
induction, unless overexpression of MyoD-enR fusion pro-
teins would bypass the normal restrictions of MyoD func-
tions. Using an antibody directed against the myc epitope
tag, all three enR fusion proteins were shown by Western
analysis to have similar stability in the embryo and by
immunocytochemistry to accumulate preferentially in the
nuclear compartment (data not shown).
In the animal cap system, MT6-MyoD(bHLH)-enR re-
pressed MyoD autoactivation efficiently, when it was co-
expressed with either mouse or Xenopus MyoD proteins
(Fig. 5a and data not shown). It also inhibited Activin-
dependent MyoD induction (Fig. 5b). In each case, repres-
sion was dose dependent and gene specific, because tran-
scription of housekeeping genes like histone H4 was
normal (data not shown), and—more importantly—Activin
induction of the other early myogenic factor XMyf-5 was
unaffected (Fig. 5d). In addition, repression required tether-
ing of the enR moiety to DNA target sites via a myogenic
FIG. 4. Dominant-negative XWnt-8 blocks MyoD activation by
bFGF/XWnt-8, but not by Activin or autocatalysis. RT/PCR anal-
ysis of relative XMyoD mRNA levels in animal caps, which were
preloaded with synthetic transcripts as indicated below the panels
(numbers refer to the injected RNA dose in pg/embryo). dnXWnt-8,
dominant-negative XWnt-8 (Hoppler et al., 1996). For the experi-
ment in column 3 (*), dnXWnt-8 RNA was injected at the two-cell
stage, followed by coinjection of bFGF/XWnt-8 RNAs at the
eight-cell stage, to provide a head start for the intereference
mutant. Panels show MyoD mRNA levels at: a, 12 hpf (i.e., shortly
after activation); or b, 24 hpf (tail bud stage; during muscle
differentiation) (n 5 3).
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FIG. 5. MT6-MyoD(bHLH)-enR blocks MyoD induction in animal caps. RT/PCR analysis of XMyoD (a–c) or XMyf-5 (d) mRNA levels in
animal caps, preloaded with synthetic transcripts as indicated below the panels (numbers refer to the injected RNA dose in pg/embryo).
Panels show: a, MT6-MyoD(bHLH)-enR inhibits MyoD autoactivation; b, MT6-MyoD(bHLH)-enR interferes with Activin-induction of
MyoD; c, Activin induction of MyoD is rescued by coinjection of MT6-MyoD(bHLH)-enR and wild-type MyoD protein; d, Activin
induction of XMyf-5 is unaffected by MT6-MyoD(bHLH)-enR; e, Synergism of autocatalysis and Activin induction. Activin protein was
applied as a 1:25 dilution of Activin containing tissue culture medium (Sokol et al., 1990); mMyoD protein was provided by RNA injection
(200 pg/embryo) (n 5 4).
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DNA-binding domain, since neither NLSMT6-enR nor
MT6-E12basic(bHLH)-enR proteins had any significant in-
fluence on the levels of the mRNAs tested (Figs. 5a–5d).
Finally, coexpression of wild-type MyoD protein rescued
the repression of Activin-driven MyoD induction by MT6-
MyoD(bHLH)-enR (Fig. 5c). Together, these results exclude
an unspecific poisoning of MyoD’s feedback loop or the
Activin signaling pathway by MT6-MyoD(bHLH)-enR. This
fusion protein is therefore a potent repressor variant of
MyoD, but not a deregulated allele.
Interestingly, Activin caused a four-fold superstimulation
when coinjected together with wild-type MyoD and MT6-
MyoD(bHLH)-enR transcripts, compared to the stimulation
caused by the same ratio of these two RNAs alone (Fig. 5,
compare the third bar in Fig. 5a with the last bar in Fig. 5c).
This observation suggested a synergism between the auto-
activation and induction modes, which has been verified in
separate experiments in the absence of MT6-MyoD(bHLH)-
enR (Fig. 5e).
Upon unilateral injection into the marginal zone at the
two-cell stage, MT6-MyoD(bHLH)-enR repressed the en-
dogenous MyoD expression in the mesoderm of embryos at
the early gastrula stage, presumably from the time point of
activation onward (Figs. 6a and 6b, Table 1). At the tadpole
stage it was found to dominantly repress muscle differen-
tiation (data not shown). The ablation of MyoD expression
was spatially correlated with the staining of the coinjected
lineage-tracer b-galactosidase, consistent with the assump-
tion that MT6-MyoD(bHLH)-enR acts in a cell-autonomous
manner.
The NLSMT6-enR control protein had no effect on MyoD
expression (Fig. 6d, Table 1). However, the MT6-E12
basic(bHLH)-enR variant had a weak but notable influence
on MyoD induction in the mesoderm (Fig. 6c, Table 1). The
basis for the more potent activity of this variant in meso-
dermal cells of the marginal zone compared to Activin-
induced animal cap cells is not known. Perhaps the induced
state of marginal zone cells is less robust at this stage, and
therefore they may be more vulnerable to interference than
animal cap cells. Certainly, ablation of MyoD induction in
the mesoderm required lower doses of MT6-MyoD(bHLH)-
enR RNA than in animal caps (Table 1 and Fig. 5). It may
also be of relevance that MyoD homodimers are known to
exist in vivo (Maleki et al., 1997). Thus, it is possible that in
these circumstances the engrailed repressor domain is re-
cruited to the MyoD locus by low amounts of pseudo-
FIG. 6. MT6-MyoD(bHLH)-enR inhibits MyoD induction in vivo. RNA in situ hybridization with an antisense XMyoDb probe at
midgastrula (NF 11), shortly after MyoD induction. (a) Uninjected control embryos. Embryos were injected equatorially into one cell at the
two-cell stage with 100 pg lacZ mRNA as lineage tracer, together with transcripts encoding the following enR-fusion proteins: (b)
MT6-MyoD(bHLH)-enR (50 pg/embryo); (c) MT6-E12basic(bHLH)-enR (50 pg/embryo); (d) NLSMT6-enR (200 pg/embryo). Asterisks mark
the location of b-galactosidase-positive cells, indicating the injected region. Inserts show representative close-ups of MyoD and
b-galactosidase staining.
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homodimers between endogenous MyoD and exogenous
MT6-E12basic(bHLH)-enR proteins. Most importantly,
however, these results indicate that MyoD autoactivation
occurs in vivo at the time of MyoD induction and therefore
is likely to be an essential component of the induction
process.
DISCUSSION
In an attempt to distinguish individual functions for
inducing factors involved in MyoD expression during Xe-
nopus mesoderm formation, we have discovered a domi-
nant regulatory mechanism, which restricts the onset of
MyoD induction to the early gastrula stage. The existence
of such a mechanism is inferred from the following obser-
vations. First, zygotic transcription has already been going
on for about 4 h (i.e., six intervals of our time course
analysis), when MyoD mRNA levels rise significantly
within 45 min (i.e., within one interval; Fig. 2). Second, de
novo MyoD induction requires not more than 45–90 min
(Fig. 3). Finally, all stimuli tested (Activin, bFGF/XWnt-8,
and MyoD) are able to transactivate other genes at earlier
developmental stages than MyoD (see Rupp et al., 1994, and
data not shown). Based on the synchrony between MyoD
induction in animal caps and its activation in the meso-
derm, this mechanism appears to operate in the whole
animal hemisphere and to be independent from germ layer
specification.
During the course of these experiments, we have found
that dominant-negative XWnt-8 has no effect on autoca-
talysis or Activin-mediated MyoD expression, while it
blocks MyoD activation by bFGF/XWnt-8 in animal caps
(Fig. 4), as well as in the marginal zone of the embryo
(Hoppler et al., 1996). These results indicate that there is
more than one mechanism by which MyoD can be acti-
vated in competent embryonic cells. Which, or how many
of these, are physiologically relevant cannot be decided at
the moment. For example, ventral marginal zone cells
express Sizzled, a secreted XWnt-8 antagonist, from the
MBT onward (Salic et al., 1997). Overexpressed Sizzled
protein blocks MyoD activation, just like dnXWnt-8. In the
wild-type situation, however, Sizzled and MyoD are coex-
pressed in the ventral marginal zone, at least for some time
(Fig. 6 and Salic et al., 1997). This suggests that the ventral
part of MyoD’s expression domain may not depend criti-
cally on zygotic XWnt-8 signaling. Examples for regional
and/or combinatorial signaling inputs into contigous ex-
pression domains have been reported for Xcad-3 and Xbra
(Northrop et al., 1995). The main finding of our study—a
temporal restriction of MyoD activation—gains its strength
from the fact that this phenomenon is observed under very
different stimulation conditions in vitro and its precise
temporal correlation with the normal MyoD activation in
the embryo. Therefore, its validity does not primarily
depend on the issue, whether each of the signaling factors
we used reflects the normal route of MyoD induction.
Involvement of an Autoregulatory Loop in MyoD
Induction
Based on MyoD’s ubiquitous low-level transcription at
the MBT we had previously postulated that the induction
process may establish MyoD’s autocatalytic loop (Rupp and
Weintraub, 1991). The observations presented here lend
further weight to this notion, although they do not prove it
yet. First, autoactivation and induction of MyoD cannot be
uncoupled temporally. Second, during the permissive pe-
riod, MyoD induction is rapid, but nevertheless requires
protein synthesis. Third, we have shown that autocatalysis
is direct, synergizes with Activin induction, and occurs in
vivo. Finally, we note that MyoD mRNA accumulates
faster in mMyoD-injected animal caps compared with
activin-induced explants (compare Figs. 3a and 3b). This
advance is expected, given that the MyoD-RNA-injected
animal caps should be ahead by one round of transcription
and translation. Interestingly, this lead is not observed
when Activin protein is applied hours before the onset of
MyoD induction (Fig. 2, 10.5 hpf), perhaps because the
induced cells are already poised for myoD transcription
under these conditions, before the gene becomes respon-
sive. This may involve endogenous MyoD protein synthe-
sized from newly transcribed MyoD mRNA at the MBT
(Rupp and Weintraub, 1991) or other proteins involved in
myoD transcription.
In summary, the results presented here describe a per-
fect correlation between autoactivation and induction-
dependent modes of MyoD expression under several inde-
pendent experimental conditions. In Drosophila, expres-
sion of the Labial homeobox protein in the midgut (Tremml
and Bienz, 1992), or of the proneural HLH protein Atonal in
the developing eye (Baker and Yu, 1997), provides a further
example for a tight coupling of feedback loops and inductive
events. It is an open question whether such coupling is
TABLE 1
Inhibition of XMyoD Expression in Vivo
RNA pg/embryo n wt (%) pt (%)
MT6-MyoD(bHLH)-enR 50 27 3 (11) 24 (89)
15 39 32 (82) 7 (18)
5 37 36 (97) 1 (3)
MT6-MyoD-E12(bHLH)-enR 50 22 19 (86) 3 (14)
15 38 38 (100) –
5 42 42 (100) –
NLS-MT6-enR 200 32 32 (100) –
100 42 42 (100) –
Uninjected N/A 54 53 (98) 1 (2)
Note. Embryos were unilaterally injected into the marginal zone
at the two-cell stage (three independent experiments). n, number of
embryos; wt, wild-type MyoD expression; pt, partial ablation of
MyoD expression.
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merely advantageous, for instance, in fast developing sys-
tems, or whether it provides a basic function for establish-
ing stable gene expression domains, as has been suggested
on theoretical grounds (see Meinhardt, 1978).
Mechanism of the Temporal Control of MyoD
Induction
Previously, we had reported that Xenopus embryos regu-
late the nuclear transport of MyoD, based on the observa-
tion that exogenous XMyoD protein was found to accumu-
late in the cytoplasm of cells in the animal pole, but to be
nuclear in the mesoderm (Rupp et al., 1994). We know now
that plasmid-borne XMyoD protein is constitutively
nuclear, and so only XMyoD protein, which is synthesized
at pre-MBT stages, may be subject to differential localiza-
tion (Rupp, unpublished results). Given that MyoD autoac-
tivation by mouse MyoD protein, which is constitutively
nuclear (Rupp et al., 1994), occurs with the normal timing,
it is very unlikely that the mechanism, which controls the
onset of MyoD induction, involves regulation of MyoD’s
nuclear transport.
Furthermore, we have microinjected several mRNA-
encoding factors known to provide a positive stimulus on
myogenic gene expression in different vertebrate organ-
isms. These include XE12, MyoD’s dimerization partner
(Lassar et al., 1991; Rashbass et al., 1992); SL-1, a member of
the MEF-2 protein family of MyoD cofactors (Chambers et
al., 1992; reviewed by Olson et al., 1995); Lef-1 and
b-catenin, which are transcriptional mediators of Wnt sig-
naling (reviewed by Heasman, 1997); and a dominant-
negative variant of protein kinase A, which mimicks hedge-
hog signaling (see Hammerschmidt et al., 1996; Mu¨nster-
berg et al., 1995). Neither of these, however, had any
influence on the timing of MyoD induction (data not
shown).
Furthermore, studies in mice have implicated Myf-5 and
Pax-3 as upstream regulators of MyoD (Maroto et al., 1997;
Tajbakhsh et al., 1997). In the frog, however, MyoD expres-
sion is independent from these factors for several reasons.
First, XMyoD is induced prior to and without spatial
overlap to Pax-3 (see Bang et al., 1997). Second, there is only
partial overlap between XmyoD and XMyf-5 expression
(Dosch et al., 1997). Finally, UV-ventralized embryos ex-
press XMyoD (Frank and Harland, 1991) but not XMyf-5 (C.
Niehrs, personal communication). Just recently, BMPs and
Nogging have been reported to determine the timing of
myogenic gene expression in the chick myotome (Reshef et
al., 1998). These findings do not explain our observations,
because MyoD induction in the frog occurs in the absence
of Noggin expression and even when BMP-4 is overex-
pressed (Frank and Harland, 1991; Re’em-Kalma et al.,
1995; Smith and Harland, 1992). Based on these results, we
expect the temporal control of MyoD induction in Xenopus
to be exerted through a novel mechanism.
Changes in Cellular Competence and MyoD
Induction
As we have shown here, MyoD cannot be induced before
10.5 hpf in development. Already at 12 hpf, MyoD induc-
tion has ended as a consequence of the general loss of
mesodermal competence (see Steinbach et al., 1997). We
believe that this tight control of MyoD induction reflects an
intrinsic function of early pattern formation, in a sense that
the temporal control may provide specificity to pleiotropic
signal transduction pathways. Concerning the onset of
MyoD induction, we note that the Wnt/b-catenin pathway
is activated in two bursts during dorsoventral axial pattern-
ing of Xenopus embryos—a transient one on the dorsal side
of the embryo, which ends shortly after the MBT, followed
by a ventrolateral one, which lasts from late blastula
through gastrula stages (reviewed by Heasman, 1997). By
gain- and loss-of-function analysis, Hoppler and colleagues
have shown that zygotic Wnt signaling is required and
sufficient for MyoD induction in all mesodermal cells,
including the Spemann organizer (Hoppler et al., 1996).
This raises the question of why MyoD is never activated
in the dorsal mesoderm. Our data suggest a simple
answer—the first burst of dorsal Wnt signaling does not
temporally overlap with the period, during which MyoD is
transcriptionally responsive. This hypothesis is in agree-
ment with data on the timing and duration of b-catenin
activity on the dorsal side of the embryo (Schneider et al.,
1996) and the timing of myoD induction (Wylie et al., 1996;
this paper). Direct testing of this hypothesis would require
means to shift MyoD’s responsiveness to earlier develop-
mental times, which are currently not available (see above).
With respect to LMC, we have shown already that an
extension of the mesodermal competence period by abla-
tion of somatic linker histones leads to an increase of the
number of MyoD-expressing cells in the mesoderm, as well
as to ectopic MyoD expression in the neural plate (Stein-
bach et al., 1997). The latter is not surprising, if one
considers the evidence implicating FGF and Wnt signaling
in both mesoderm and neural patterning (see McGrew et
al., 1997).
It is likely then that MyoD’s expression pattern in the
embryo is equally determined by local signaling as well as
by temporal aspects of cellular competence. Given that
similar conclusions have been formulated in a number of
unrelated experimental studies for both Xenopus (Gamill
and Sive, 1997; Tada et al., 1997) and Drosophila (Parkhurst
and Ish-Horowicz, 1991; Rodriguez et al., 1990; Royet and
Finkelstein, 1995), timing requirements may be a rather
common feature of embryonic patterning processes. A de-
tailed analysis of the mechanism(s) controlling cellular
competence in various species will help address these
questions in the future, and undoubtedly be a key issue for
our understanding of signal transduction specificity during
development.
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